Hello, and welcome to the Deutsche Bank Virtual Investor Conference, dbVIC. This is Zafar Aziz from the Deutsche Bank team. I'm pleased to welcome our next presentation from Belite Bio, whose ADRs are ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor Activity IND Submission for CR-001 On Track for Fourth Quarter of 2025 to ...
TipRanks on MSN
Crescent Biopharma to present preclinical data from CR-001
Crescent Biopharma (CBIO) announced that preclinical data from CR-001, its PD-1 x VEGF bispecific antibody being developed for solid tumors, will ...
University of Texas at Dallas researchers have developed biosensor technology that, when combined with artificial ...
Takeaways Rhode Island’s amended Payment of Wages law requires employers to provide written notice to each employee at the start of employment. The notice must include the employee’s pay, allowances, ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the launch of AdvanceAD-Tx™, a gene expression profile (GEP) test ...
Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to ...
The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...
Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...
Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...
Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback